History

The Pierone Research Institute:
A Whole Family Health Center Initiative

The Pierone Research Institute (TPRI) serves as the dedicated research arm of Whole Family Health Center, continuing a legacy of innovation in infectious disease care. Founded in 1997 by Dr. Gerald Pierone, Jr. in Fort Pierce, Florida, TPRI began as the AIDS Research and Treatment Center of the Treasure Coast (ARTCTC)—a center committed to providing high-quality HIV care, prevention, education, and testing.

Today, TPRI gives patients access to cutting-edge clinical trials focused on improving HIV treatment, managing related complications, and supporting the global search for a cure. Many of these trials are sponsored by leading pharmaceutical companies or inspired by Dr. Pierone’s own FDA-submitted protocols.

During the COVID-19 pandemic, TPRI partnered with the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institutes of Health (NIH) to conduct critical research on monoclonal antibody therapies. This work contributed to several treatments receiving Emergency Use Authorization (EUA) from the FDA, helping to expand care options during a global health crisis.

TPRI remains committed to advancing research that improves outcomes for our patients and strengthens the future of community health.



What Is a Clinical Trial? 
A clinical trial is a research study designed to evaluate the safety and effectiveness of a medical, surgical, or behavioral intervention. These trials are essential for developing new treatments and improving existing ones.

Participants in clinical trials receive specific interventions based on a detailed research plan or protocol. These protocols are created by pharmaceutical sponsors or by Dr. Gerald Pierone, who serves as the research director or site investigator for many studies conducted at The Pierone Research Institute.

Clinical trials help answer key questions, such as:

  • Is the treatment safe?
  • Does it work better than current options?
  • Are there fewer or more manageable side effects?

For example, a trial may test a new medication to see if it more effectively lowers blood pressure compared to current treatments.

What to Expect

  • Trials may last from a single visit to several months or even years of follow-up.
  • Most studies involve lab tests, questionnaires, and health assessments.
  • There is no cost to participate.
  • Some sponsors offer financial compensation for time and travel.

By joining a clinical trial, you contribute to medical advancements and may gain early access to promising new therapies.



If you wish to find out more about our current research programs, please speak to your provider or call the research department at (772) 978-9556.

We also have summer research opportunities for pre-medical and medical students to gain experience with medical research in a meaningful way.

For more information about Clinical Trials: https://clinicaltrials.gov and https://nia.nih.gov


Clinical Trials & Research Contributions
The Pierone Research Institute has conducted a wide range of clinical trials in partnership with pharmaceutical sponsors, focusing on both infectious and chronic diseases. These studies support our mission to advance care and improve outcomes for patients across the Treasure Coast and beyond.

Clinical Trials Completed with Sponsors
Our team has participated in industry-sponsored trials in the following areas:

  • HIV/AIDS
  • HIV-related facial lipoatrophy
  • HIV neuropathy
  • Herpes Simplex Virus
  • Influenza
  • Hepatitis B & C
  • Gonorrhea
  • Cardiovascular health (Hypertension, Atrial Fibrillation, Hyperlipidemia)
  • COVID-19

Investigator-Initiated Studies by Dr. Gerald Pierone
Dr. Pierone has personally designed and submitted FDA-approved clinical trial protocols, including:

  • The HEART Study (HIV and cardiovascular risk)
  • Kaletra Salvage Trial
  • Zerit Phase IV Open-Label Switch Trial
  • Bellafill (Artefill) for HIV-related facial lipoatrophy

Scientific Posters & Conference Presentations
Our research team has shared findings at leading medical conferences around the world, including:

  • Genotypic and Phenotypic Resistance in Lopinavir/Ritonavir Monotherapy – HIV DART 2002; ICAAC 2004
  • Lipid Improvement After Switching from Stavudine to Tenofovir – HIV DART, Naples 2002
  • Epidemic Update – CROI 2003
  • Dual Therapy with Etravirine and Raltegravir – HIV DART 2008
  • Cardiovascular Surrogate Markers in HIV Patients – Bangkok 2004
  • Injectable Poly-L-Lactic Acid for HIV Facial Lipoatrophy: 1-Year Interim of 5-Year Study – AAD Boston 2009
  • Nocturnal Oxygen Desaturation in HIV-Positive Patients – International AIDS Conference, Melbourne 2014
  • Polymethylmethacrylate for HIV-Associated Facial Lipoatrophy – HIV DART 2014, Miami, FL

To schedule an appointment call:
1-877-345-WFHC (9342)

To make an appointment please call 1-877-345-WFHC (9342)

Skip to content